Difluoromethyl-1,3,4-oxadiazoles Are Selective, Mechanism-Based, and Essentially Irreversible Inhibitors of Histone Deacetylase <b>6</b>Beate König, Finn K. Hansen, P. R. Watson et al.|Journal of Medicinal Chemistry|2023Cited by 46
Development of Fluorinated Peptoid-Based Histone Deacetylase (HDAC) Inhibitors for Therapy-Resistant Acute LeukemiaNina Reßing, Finn K. Hansen, Julian Schliehe‐Diecks et al.|Journal of Medicinal Chemistry|2022Cited by 32
Photocaged Histone Deacetylase Inhibitors as Prodrugs in Targeted Cancer TherapyFabian B. Kraft, Finn K. Hansen|Pharmaceuticals|2023Cited by 28
Development of the First-in-Class FEM1B-Recruiting Histone Deacetylase DegradersFelix Feller, Finn K. Hansen|Journal of Medicinal Chemistry|2025Cited by 13
Exploring Alternative Zinc-Binding Groups in Histone Deacetylase (HDAC) Inhibitors Uncovers <b>DS-103</b> as a Potent Ethylhydrazide-Based HDAC Inhibitor with Chemosensitizing PropertiesDaniel Stopper, Finn K. Hansen, David W. Christianson et al.|Journal of Medicinal Chemistry|2025Cited by 12